New pill shows promise for Hard-to-Treat cancers
NCT ID NCT06558513
First seen Jan 10, 2026 · Last updated May 14, 2026 · Updated 18 times
Summary
This study tested an experimental tablet called XNW5004 in 120 adults with advanced tumors or lymphoma that had come back or stopped responding to standard treatments. The main goals were to check the drug's safety and find the best dose. Researchers also looked at how the drug moves through the body and whether it shows any early signs of shrinking tumors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hematology Hospital, Chinese Academy of Medical Sciences
Tianjin, China
Conditions
Explore the condition pages connected to this study.